A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068 · see citing works

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · see citing works

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,169 · see citing works

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · see citing works

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,947 · see citing works

Structure, Function, and Evolution of Coronavirus Spike Proteins

Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740 · see citing works

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684 · see citing works

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453 · see citing works

Coronavirus Disease 2019 (COVID-19): A Perspective from China

Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020) · Radiology · doi:10.1148/radiol.2020200490 · Cited by 2,070 · see citing works

Coronaviruses — drug discovery and therapeutic options

Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,689 · see citing works

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Coutard, B., Valle, C., de Lamballerie, X. N., Canard, B., Seidah, N. G., & Decroly, É. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,685 · see citing works

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Peeri, N. C., Shrestha, N., Rahman, M. S., Zaki, R., Tan, Z., Bibi, S., Baghbanzadeh, M., Aghamohammadi, N., Zhang, W., & Haque, U. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa033 · Cited by 1,610 · see citing works

Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05762-w · Cited by 1,410 · see citing works

Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein

Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012) · Viruses · doi:10.3390/v4061011 · Cited by 1,368 · see citing works

Journal of General Internal Medicine

(2013) · Journal of General Internal Medicine · doi:10.1007/11606.1525-1497 · Cited by 1,284 · see citing works

COVID-19: what is next for public health?

Heymann, D. L., & Shindo, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30374-3 · Cited by 1,146 · see citing works

COVID-19: combining antiviral and anti-inflammatory treatments

Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117 · see citing works

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116 · see citing works

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45538 · Cited by 965 · see citing works

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

Millet, J. K., & Whittaker, G. R. (2014) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 887 · see citing works

Host-directed therapies for bacterial and viral infections

Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. F. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 847 · see citing works

Structure analysis of the receptor binding of 2019-nCoV

Chen, Y., Guo, Y., Pan, Y., & Zhao, Z. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.071 · Cited by 806 · see citing works

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics

Gurwitz, D. (2020) · Drug Development Research · doi:10.1002/ddr.21656 · Cited by 802 · see citing works

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases

Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030324 · Cited by 722 · see citing works

A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

Wong, S. K., Li, W., Moore, M. J., Choe, H., & Farzan, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300520200 · Cited by 690 · see citing works

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 673 · see citing works

Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus

Huang, I., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chī, X., Dŏng, L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001258 · Cited by 604 · see citing works

Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions

van Doremalen, N., Bushmaker, T., & Munster, V. J. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.38.20590 · Cited by 580 · see citing works

Drug targets for corona virus: A systematic review

Medhi, B., Prajapat#, M., Sarma#, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., et al. (2020) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_115_20 · Cited by 499 · see citing works

Cold Spring Harbor Perspectives in MedicinePreprint

(2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect_med · Cited by 467 · see citing works

The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases

Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 436 · see citing works

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle

Cong, Y., Ulaşlı, M., Schepers, H., Mauthe, M., V’kovski, P., Kriegenburg, F., Thiel, V., de Haan, C. A. M., & Reggiori, F. (2019) · Journal of Virology · doi:10.1128/jvi.01925-19 · Cited by 384 · see citing works

Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G., Bosch, B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 380 · see citing works

Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system

Xu, J., Yang, J., Chen, J., Luo, Q., Zhang, Q., & Zhang, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7546 · Cited by 354 · see citing works

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses.

Vlasak, R., Luytjes, W., Spaan, W. J. M., & Palese, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4526 · Cited by 351 · see citing works

Furin‐mediated protein processing in infectious diseases and cancer

Braun, E., & Sauter, D. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1073 · Cited by 345 · see citing works

Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence

Heald-Sargent, T. A., & Gallagher, T. (2012) · Viruses · doi:10.3390/v4040557 · Cited by 322 · see citing works

Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses

Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. M., Proll, S. C., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 307 · see citing works

MERS-CoV spike protein: a key target for antivirals

Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F., & Jiang, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1271415 · Cited by 301 · see citing works

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

Zhou, G., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45123 · Cited by 262 · see citing works

Teicoplanin: an alternative drug for the treatment of COVID-19?

Baron, S. A., Devaux, C. A., Colson, P., Raoult, D., & Rolain, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105944 · Cited by 245 · see citing works

Proprotein convertases: lessons from knockouts

Scamuffa, N., Calvo, F. M., Chrétien, M., Seidah, N. G., & Khatib, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5491rev · Cited by 224 · see citing works

A model of the ACE2 structure and function as a SARS-CoV receptor

Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.081 · Cited by 209 · see citing works

Mutation in Spike Protein Cleavage Site and Pathogenesis of Feline Coronavirus

Licitra, B. N., Millet, J. K., Regan, A. D., Hamilton, B. S., Rinaldi, V. D., Duhamel, G. E., & Whittaker, G. R. (2013) · Emerging infectious diseases · doi:10.3201/eid1907.121094 · Cited by 206 · see citing works

Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies

Li, C., Li, W., de Esesarte, E. L., Guo, H., van den Elzen, P., Aarts, E., van den Born, E., Rottier, P. J. M., & Bosch, B. (2017) · Journal of Virology · doi:10.1128/jvi.00273-17 · Cited by 200 · see citing works

Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells

Yamada, Y., & Liu, D. X. (2009) · Journal of Virology · doi:10.1128/jvi.00613-09 · Cited by 185 · see citing works

COVID-19 Docking Server: a meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19

Kong, R., Yang, G., Xue, R., Liu, M., Wang, F., Hu, J., Guo, X., & Chang, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa645 · Cited by 170 · see citing works

Emergence of a novel coronavirus causing respiratory illness from Wuhan, China

Tang, J. W.-T., Tambyah, P. A., & Hui, D. S. C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.01.014 · Cited by 160 · see citing works

Emergence of a novel human coronavirus threatening human health

Poon, L. L. M., & Peiris, M. J. S. (2020) · Nature Medicine · doi:10.1038/s41591-020-0796-5 · Cited by 158 · see citing works

Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization

Kleine‐Weber, H., Elzayat, M. T., Wang, L., Graham, B. S., Müller, M. A., Drosten, C., Pöhlmann, S., & Hoffmann, M. (2018) · Journal of Virology · doi:10.1128/jvi.01381-18 · Cited by 143 · see citing works

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

Bernstein, D. I., Guptill, J. T., Naficy, A. B., Nachbagauer, R., Scorza, F. B., Feser, J., Wilson, P. C., Solórzano, A., der Wielen, M. V., Walter, E. B., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30393-7 · Cited by 140 · see citing works

The prediction of streptococcal pharyngitis in adults

Komaroff, A. L., Pass, T. M., Aronson, M. D., Ervin, C. T., Cretin, S., Winickoff, R. N., & Branch, W. T. (1986) · Journal of General Internal Medicine · doi:10.1007/bf02596317 · Cited by 135 · see citing works

Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function

Jaimes, J. A., & Whittaker, G. R. (2018) · Virology · doi:10.1016/j.virol.2017.12.027 · Cited by 134 · see citing works

Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis

Porter, E., Tasker, S., Day, M. J., Harley, R., Kipar, A., Siddell, S. G., & Helps, C. R. (2014) · Veterinary Research · doi:10.1186/1297-9716-45-49 · Cited by 110 · see citing works

A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2

Struck, A., Axmann, M., Pfefferle, S., Drosten, C., & Meyer, B. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2011.12.012 · Cited by 97 · see citing works

Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak

Kim, Y., Cheon, S., Min, C.-K., Sohn, K. M., Kang, Y. J., Cha, Y., Kang, J.-I., Han, S. K., Ha, N.-Y., Kim, G., et al. (2016) · mBio · doi:10.1128/mbio.00019-16 · Cited by 92 · see citing works

Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2

Mathewson, A. C., Bishop, A., Yao, Y., Kemp, F., Ren, J., Chen, H., Xu, X., Berkhout, B., van der Hoek, L., & Jones, I. M. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/003962-0 · Cited by 79 · see citing works

Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus

Bergeron, É., Vincent, M. J., Wickham, L., Hamelin, J., Basak, A., Nichol, S. T., Chrétien, M., & Seidah, N. G. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.063 · Cited by 72 · see citing works

Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host

Zheng, J. H., & Perlman, S. M. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.11.002 · Cited by 66 · see citing works

Promising approaches for the treatment and prevention of viral respiratory illnesses

Papadopoulos, N. G., Megremis, S., Kitsioulis, N. A., Vangelatou, O., West, P., & Xepapadaki, P. V. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.001 · Cited by 60 · see citing works

Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site

Jin, X., Xu, K., Jiang, P., Lian, J., Hao, S., Yao, H., Jia, H., Zhang, Y., Zheng, L., zheng, N., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1781551 · Cited by 59 · see citing works

SARS-CoV-2 transmission dynamics in Belarus in 2020 revealed by genomic and incidence data analysis

Nemira, A., Adeniyi, A. E., Леонидовна, Г. Е., Bulda, K. Y., Valentovich, L. N., Kras’ko, A. G., Glebova, O., Kirpich, A., & Skums, P. (2021) · Communications Medicine · doi:10.1038/s43856-021-00031-1 · Cited by 55 · see citing works

TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1

Zmora, P., Hoffmann, M., Kollmus, H., Moldenhauer, A.-S., Danov, O., Braun, A. C., Winkler, M., Schughart, K., & Pöhlmann, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001273 · Cited by 55 · see citing works

90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1

Lodermeyer, V., Suhr, K., Schrott, N., Kolbe, C., Stürzel, C. M., Krnavek, D., Münch, J., Dietz, C., Waldmann, T., Kirchhoff, F., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-111 · Cited by 50 · see citing works

Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding

Lai, J. C. C., Karunarathna, H. M. T. K., Wong, H. H., Peiris, J. S. M., & Nicholls, J. M. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1581034 · Cited by 50 · see citing works

A Single Point Mutation Creating a Furin Cleavage Site in the Spike Protein Renders Porcine Epidemic Diarrhea Coronavirus Trypsin Independent for Cell Entry and Fusion

Li, W., Wicht, O., van Kuppeveld, F. J. M., He, Q., Rottier, P. J. M., & Bosch, B. (2015) · Journal of Virology · doi:10.1128/jvi.00356-15 · Cited by 50 · see citing works

Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor

Dahms, S. O., Jiao, G., & Than, M. E. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01110 · Cited by 39 · see citing works

Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): Revision of screening strategies urgently needed

Amer, H., Alqahtani, A., Alaklobi, F., Altayeb, J., & Memish, Z. A. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.04.001 · Cited by 39 · see citing works

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target

Veljković, V., Vergara‐Alert, J., Segalés, J., & Paessler, S. (2020) · F1000Research · doi:10.12688/f1000research.22149.4 · Cited by 38 · see citing works

Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor

Dahms, S. O., Jiao, G., & Than, M. E. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00633 · Cited by 37 · see citing works

Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder

Kim, W. J., Zekas, E., Lodge, R., Susan‐Resiga, D., Marcinkiewicz, E., Essalmani, R., Mihara, K., Ramachandran, R., Asahchop, E. L., Gelman, B. B., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00764-15 · Cited by 34 · see citing works

Virtual Screening of Inhibitors Against Spike Glycoprotein of 2019 Novel Corona Virus: A Drug Repurposing ApproachPreprint

Senathilake, K. S., Samarakoon, S. R., & Tennekoon, K. H. (2020) · Preprints.org · doi:10.20944/preprints202003.0042.v1 · Cited by 33 · see citing works

Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector

Li, K., Li, H., Bi, Z., Song, D., Zhang, F., Lei, D., Luo, S., Li, Z., Gong, W., Huang, D., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.03.010 · Cited by 28 · see citing works

Critical Review of the Present Situation of Corona Virus in ChinaPreprint

Khan, N., & Fahad, S. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3543177 · Cited by 24 · see citing works

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Jaimes, J. A., Millet, J. K., Goldstein, M. E., Whittaker, G. R., & Straus, M. R. (2019) · Journal of Visualized Experiments · doi:10.3791/58892 · Cited by 22 · see citing works

Experimental Approaches to Identify Host Factors Important for Influenza VirusPreprint

Schaack, G. A., & Mehle, A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038521 · Cited by 13 · see citing works

A Fluorogenic Peptide Containing the Processing Site of Human SARS Corona Virus S‐Protein: Kinetic Evaluation and NMR Structure Elucidation

Basak, A., Mitra, A., Basak, S., Pasko, C., Chrétien, M., & Seaton, P. J. (2007) · ChemBioChem · doi:10.1002/cbic.200700007 · Cited by 11 · see citing works

Immunogenicity and protective efficacy of recombinant fusion proteins containing spike protein of infectious bronchitis virus and hemagglutinin of H3N2 influenza virus in chickens

Yin, L., Zeng, Y., Wang, W., Wei, Y., Xue, C., & Cao, Y. (2016) · Virus Research · doi:10.1016/j.virusres.2016.07.010 · Cited by 10 · see citing works

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target

Veljković, V., Vergara‐Alert, J., Segalés, J., & Paessler, S. (2020) · F1000Research · doi:10.12688/f1000research.22149.1 · Cited by 6 · see citing works

Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques

Koopman, G., Mortier, D., Michels, S., Hofman, S., Fagrouch, Z. C., Remarque, E. J., Verschoor, E. J., Mooij, P., & Bogers, W. M. J. M. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001251 · Cited by 6 · see citing works

Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV

Li, Y., Gao, H., Xiao, Y., Weng, T.-H., Yu, D.-S., Hu, C. W., Yao, H., & Li, L. (2018) · International Conference on Information Technology in Medicine and Education · doi:10.1109/itme.2018.00026 · Cited by 2 · see citing works

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Huang, Y., Yang, C., Xu, X.-F., Xü, W., & Liu, S. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,207 · see citing works

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works

Emerging Pandemic Diseases: How We Got to COVID-19

Morens, D. M., & Fauci, A. S. (2020) · Cell · doi:10.1016/j.cell.2020.08.021 · Cited by 720 · see citing works

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Boopathi, S., Poma, A. B., & Kolandaivel, P. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758788 · Cited by 531 · see citing works

COVID-19: Drug Targets and Potential Treatments

Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00606 · Cited by 449 · see citing works

Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

Hulswit, R. J. G., Lang, Y., Bakkers, M. J. G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F. J. M., Boons, G., Bosch, B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809667116 · Cited by 380 · see citing works

An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study

Das, S., Sarmah, S., Lyndem, S., & Roy, A. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763201 · Cited by 379 · see citing works

Using X-ray images and deep learning for automated detection of coronavirus disease

Asnaoui, K. E., & Chawki, Y. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767212 · Cited by 363 · see citing works

Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1760137 · Cited by 354 · see citing works

A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2

Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 339 · see citing works

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study

Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779818 · Cited by 302 · see citing works

SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective

Elfiky, A. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761882 · Cited by 284 · see citing works

COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics

Yesudhas, D., Srivastava, A., & Gromiha, M. M. (2020) · Infection · doi:10.1007/s15010-020-01516-2 · Cited by 280 · see citing works

Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

Samuel, R. M., Majd, H., Richter, M. N., Ghazizadeh, Z., Zekavat, S. M., Navickas, A., Ramirez, J. T., Asgharian, H., Simoneau, C. R., Bonser, L. R., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.009 · Cited by 262 · see citing works

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development

Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A., & Ray, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796811 · Cited by 258 · see citing works

Stilbene-based natural compounds as promising drug candidates against COVID-19

Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1762743 · Cited by 243 · see citing works

Natural products may interfere with SARS-CoV-2 attachment to the host cell

Elfiky, A. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761881 · Cited by 218 · see citing works

Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

Ou, T., Mou, H., Zhang, L., Ojha, A., Choe, H., & Farzan, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009212 · Cited by 208 · see citing works

Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity

Sakaguchi, W., Kubota, N., Shimizu, T., Saruta, J., Fuchida, S., Kawata, A., Yamamoto, Y., Sugimoto, M., Yakeishi, M., & Tsukinoki, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176000 · Cited by 200 · see citing works

Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches

Kumar, A., Choudhir, G., Shukla, S. K., Sharma, M., Tyagi, P. K., Bhushan, A., & Rathore, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772112 · Cited by 210 · see citing works

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): anin silicoscreening of alkaloids and terpenoids from African medicinal plants

Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764868 · Cited by 199 · see citing works

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

Murgolo, N., Therien, A. G., Howell, B. J., Klein, D. J., Koeplinger, K. A., Lieberman, L. A., Adam, G. C., Flynn, J. A., McKenna, P. M., Swaminathan, G., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009225 · Cited by 189 · see citing works

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach

Samad, A., Ahammad, F., Nain, Z., Alam, R., Imon, R. R., Hasan, M., & Rahman, M. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792347 · Cited by 191 · see citing works

Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking

Engin, A. B., Engin, A., & Engin, A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103411 · Cited by 187 · see citing works

An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1762741 · Cited by 186 · see citing works

In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2

Prasanth, D., Murahari, M., Chandramohan, V., Panda, S. P., Rao, A. L., & Guntupalli, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779129 · Cited by 172 · see citing works

Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells

Kumar, V., Dhanjal, J. K., Bhargava, P., Kaul, A., Wang, J., Zhang, H., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775704 · Cited by 171 · see citing works

In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria

Abdelli, I., Hassani, F., Brikci, S. B., & Ghalem, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763199 · Cited by 172 · see citing works

Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study

Khan, M. T., Ali, A., Wang, Q., Irfan, M., Khan, A., Zeb, M. T., Zhang, Y.-J., Chinnasamy, S., & Wei, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1769733 · Cited by 167 · see citing works

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

Ramarao, P., Joshi, G., & Jagadeesh, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109721 · Cited by 155 · see citing works

Antiviral effects of probiotic metabolites on COVID-19

Anwar, F., Altayb, H. N., Al-Abbasi, F. A., Al‐Malki, A. L., Kamal, M. A., & Kumar, V. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775123 · Cited by 152 · see citing works

Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M pro ) of SARS-CoV-2 and inhibit its activity

Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772108 · Cited by 149 · see citing works

Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2

Al-Khafaji, K., AL-Duhaidahawi, D., & Taşkın‐Tok, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764392 · Cited by 144 · see citing works

Design of multi-epitope vaccine candidate against SARS-CoV-2: ain-silicostudy

Peele, K. A., Srihansa, T., Krupanidhi, S., Ayyagari, V. S., & Venkateswarulu, T. C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1770127 · Cited by 134 · see citing works

Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases

Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Mubeen, B., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Antioxidants · doi:10.3390/antiox11020232 · Cited by 142 · see citing works

Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms

Quimque, M. T. J., Notarte, K. I., Fernandez, R. A. T., Mendoza, M. A. O., Liman, R. A. D., Lim, J. A. K., Pilapil, L. A. E., Ong, J. K. H., Pastrana, A. M., Khan, A., et al. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1776639 · Cited by 130 · see citing works

Assessing the mechanism of barriers towards green finance and public spending in small and medium enterprises from developed countries

Chien, F., Ngo, T. Q., Hsu, C., Chau, K. Y., & Iram, R. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14907-1 · Cited by 125 · see citing works

Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19

Senapati, S., Banerjee, P., Bhagavatula, S., Kushwaha, P. P., & Kumar, S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01262-w · Cited by 124 · see citing works

Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary

Hendaus, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767691 · Cited by 117 · see citing works

Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach

Chikhale, R. V., Gurav, S. S., Patil, R. B., Sinha, S. K., Prasad, S. K., Shakya, A., Shrivastava, S. K., Gurav, N. S., & Prasad, R. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778539 · Cited by 117 · see citing works

The biological activities of postbiotics in gastrointestinal disorders

Abbasi, A., Rad, A. H., Ghasempour, Z., Sabahi, S., Kafil, H. S., Hasannezhad, P., Saadat, Y. R., & Shahbazi, N. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1895061 · Cited by 114 · see citing works

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19

Adem, Ş., Eyüpoğlu, V., Ibrahim, I. M., Sarfraz, I., Rasul, A., Ali, M., & Elfiky, A. A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105452 · Cited by 111 · see citing works

Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors

Amin, S. A., Ghosh, K., Gayen, S., & Jha, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1780946 · Cited by 108 · see citing works

Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach

Lakshmi, S. A., Shafreen, R. B., Priya, A., & Pandian, S. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778537 · Cited by 103 · see citing works

The Inflammasome in Times of COVID-19

Vaccari, J. C. D. R., Dietrich, W. D., Keane, R. W., & Vaccari, J. P. D. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583373 · Cited by 102 · see citing works

First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations

Paniri, A., Hosseini, M. M., & Akhavan‐Niaki, H. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767690 · Cited by 101 · see citing works

Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2

Khelfaoui, H., Harkati, D., & Saleh, B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803967 · Cited by 100 · see citing works

FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication

Lobo-Galo, N., Terrazas-López, M., Martı́nez-Martı́nez, A., & Díaz‐Sánchez, Á. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764393 · Cited by 98 · see citing works

Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19

Sehailia, M., & Chemat, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796809 · Cited by 96 · see citing works

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches

Gioia, M., Ciaccio, C., Calligari, P. A., Simone, G. D., Sbardella, D., Tundo, G. R., Fasciglione, G. F., di Masi, A., Pierro, D. D., Bocedi, A., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114225 · Cited by 97 · see citing works

Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases

Yao, Y., Wang, H., & Liu, Z. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13746 · Cited by 92 · see citing works

Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects

Varahachalam, S. P., Lahooti, B., Chamaneh, M., Bagchi, S., Chhibber, T., Morris, K., Bolanos, J. F., Kim, N., & Kaushik, A. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s283686 · Cited by 94 · see citing works

Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations

Sk, M. F., Roy, R., Jonniya, N. A., Poddar, S., & Kar, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768149 · Cited by 91 · see citing works

Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target

Arun, K. G., Sharanya, C. S., Jayanandan, A., Francis, D., & Sadasivan, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779819 · Cited by 91 · see citing works

Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor

Veeramachaneni, G. K., Thunuguntla, V. B. S. C., Bobbillapati, J., & Bondili, J. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773318 · Cited by 86 · see citing works

In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19

Chikhale, R. V., Sinha, S. K., Patil, R. B., Prasad, S. K., Shakya, A., Gurav, N. S., Prasad, R. S., Dhaswadikar, S. R., Wanjari, M., & Gurav, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784289 · Cited by 86 · see citing works

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?

Indari, O., Jakhmola, S., Manivannan, E., & Jha, H. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632677 · Cited by 85 · see citing works

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 83 · see citing works

Oral antiviral treatments for COVID-19: opportunities and challenges

Rahmah, L., Abarikwu, S. O., Arero, A. G., Essouma, M., Jibril, A. T., Fal, A., Flisiak, R., Makuku, R., Marquez, L. P., Mohamed, K., et al. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00388-7 · Cited by 88 · see citing works

Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus

Adeoye, A. O., Oso, B. J., Olaoye, I. F., Tijjani, H., & Adebayo, A. I. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1765876 · Cited by 83 · see citing works

A global picture: therapeutic perspectives for COVID-19

Chavda, V., Kapadia, C., Soni, S., Prajapati, R., Chauhan, S., Yallapu, M., & Apostolopoulos, V. (2022) · Immunotherapy · doi:10.2217/imt-2021-0168 · Cited by 66 · see citing works

Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach

Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768902 · Cited by 82 · see citing works

Drug targets for COVID-19 therapeutics: Ongoing global efforts

Saxena, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00067-w · Cited by 83 · see citing works

Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation

Kar, P., Sharma, N. R., Singh, B., Sen, A., & Roy, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1780947 · Cited by 80 · see citing works

Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2

Yadav, R., Imran, M., Dhamija, P., Chaurasia, D. K., & Handu, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796812 · Cited by 79 · see citing works

Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines

Omrani, M., Keshavarz, M., Ebrahimi, S. N., Mehrabi, M., McGaw, L. J., Abdalla, M. A., & Mehrbod, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.586993 · Cited by 79 · see citing works

Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence

Vankadari, N. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c01698 · Cited by 78 · see citing works

Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies

Chikhale, R. V., Gupta, V. K., Eldesoky, G. E., Wabaidur, S. M., Patil, S. A., & Islam, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1798813 · Cited by 77 · see citing works

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach

Naik, V. R., Munikumar, M., Ungarala, R., Medithi, S., Goudar, G., Naresh, P., Kumar, B. N., & Rajkumar, H. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1781694 · Cited by 76 · see citing works

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

Beura, S., & Chetti, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1772111 · Cited by 73 · see citing works

Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence

Vankadari, N., Jeyasankar, N. N., & Lopes, W. J. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02818 · Cited by 73 · see citing works

Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World

Augustine, R., Das, S., Hasan, A., Abhilash, S., Salam, S. A., Augustine, P., Dalvi, Y. B., Varghese, R., Primavera, R., Yassine, H. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103372 · Cited by 71 · see citing works

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza

Saadat, Y. R., Khatibi, S. M. H., Vahed, S. Z., & Ardalan, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.725528 · Cited by 70 · see citing works

Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence

Singla, R., Mishra, A., Joshi, R., Jha, S., Sharma, A. R., Upadhyay, S., Sarma, P., Prakash, A., & Medhi, B. (2020) · Veterinary Research Communications · doi:10.1007/s11259-020-09781-0 · Cited by 67 · see citing works

Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent

Basit, A., Ali, T., & Rehman, S. U. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768150 · Cited by 65 · see citing works

In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2

Rout, J., Swain, B. C., & Tripathy, U. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1819879 · Cited by 66 · see citing works

Covalent Organic Frameworks (COFs) as Multi-Target Multifunctional Frameworks

Bukhari, S. N. A., Ahmed, N., Amjad, M. W., Hussain, M. A., Elsherif, M. A., Ejaz, H., & Alotaibi, N. H. (2023) · Polymers · doi:10.3390/polym15020267 · Cited by 64 · see citing works

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection

Metzdorf, K., Jacobsen, H., Greweling‐Pils, M. C., Hoffmann, M., Lüddecke, T., Miller, F., Melcher, L., Kempf, A. M., Nehlmeier, I., Bruder, D., et al. (2023) · Viruses · doi:10.3390/v15020271 · Cited by 64 · see citing works

The Cellular basis of loss of smell in 2019-nCoV-infected individuals

Gupta, K., Mohanty, S. K., Mittal, A., Kalra, S., Kumar, S., Mishra, T., Ahuja, J., Sengupta, D., & Ahuja, G. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa168 · Cited by 62 · see citing works

Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach

Mohammad, T., Choudhury, A., Habib, I., Asrani, P., Mathur, Y., Umair, M., Anjum, F., Shafie, A., Yadav, D. K., & Hassan, M. I. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765039 · Cited by 60 · see citing works

Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19

Quitadamo, P. A., Comegna, L., & Cristalli, P. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.589736 · Cited by 60 · see citing works

Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL pro )

Koulgi, S., Jani, V., N, M. U. V., Sonavane, U., Nath, A. K., Darbari, H., & Joshi, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792344 · Cited by 56 · see citing works

A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19

Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 55 · see citing works

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer

Cai, Y., Gao, K., Peng, B., Xu, Z., Peng, J., Li, J., Chen, X., Zeng, S., Hu, K., & Yan, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.781033 · Cited by 55 · see citing works

Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer

Sarvmeili, J., Kohnehrouz, B. B., Gholizadeh, A., Shanehbandi, D., & Ofoghi, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-61025-2 · Cited by 54 · see citing works

Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2

Yadav, R., Imran, M., Dhamija, P., Suchal, K., & Handu, S. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1778536 · Cited by 53 · see citing works

The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID‐19 Patients

Soltani, S., Zakeri, A., Zandi, M., Kesheh, M. M., Tabibzadeh, A., Dastranj, M., Faramarzi, S., Didehdar, M., Hafezi, H., Hosseini, P., et al. (2021) · BioMed Research International · doi:10.1155/2021/6670798 · Cited by 52 · see citing works

Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation

Augustine, R., Abhilash, S., Nayeem, A., Salam, S. A., Augustine, P., Dan, P., Maureira, P., Mraiche, F., Gentile, C., Hansbro, P. M., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109738 · Cited by 53 · see citing works

Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines

Tablizo, F. A., Kim, K. M., Lapid, C. M., Castro, M. J. R., Yangzon, M. S. L., Maralit, B. A., Ayes, M. E. C., Cutiongco-de la Paz, E. M., De Guzman, A. R., Yap, J. M. C., et al. (2021) · doi:10.1101/2021.03.03.21252812 · Cited by 46 · see citing works

Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function

Edenfield, R. C., & Easley, C. A. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00542-5 · Cited by 53 · see citing works

Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase

Babadaei, M. M. N., Hasan, A., Vahdani, Y., Bloukh, S. H., Sharifi, M., Kachooei, E., Haghighat, S., & Falahati, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767210 · Cited by 50 · see citing works

Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease

Choudhury, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1771424 · Cited by 50 · see citing works

Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners

Bordea, I. R., Xhajanka, E., Candrea, S., Bran, S., Onisor, F. G., Inchingolo, A. D., Malcangi, G., Pham, V. H., Inchingolo, A. M., Scarano, A., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111704 · Cited by 50 · see citing works

A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery

Ulhas, R. S., & Praveen, N. (2021) · VirusDisease · doi:10.1007/s13337-021-00683-6 · Cited by 50 · see citing works

Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein

Wang, Y., Wu, Z., Hu, W., Hao, P., & Yang, S. (2021) · ACS Omega · doi:10.1021/acsomega.1c01785 · Cited by 49 · see citing works

Cyanobacterial metabolites as promising drug leads against the M pro and PL pro of SARS-CoV-2: an in silico analysis

Naidoo, D., Roy, A., Kar, P., Mutanda, T., & Anandraj, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1794972 · Cited by 50 · see citing works

The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2

Shagufta, & Ahmad, I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113157 · Cited by 48 · see citing works

New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19

Li, T., Fu, J., Cheng, J., Elfiky, A. A., Wei, C., & Fu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166680 · Cited by 48 · see citing works

SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030525 · Cited by 47 · see citing works

Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)

Bibi, S., Hasan, M. M., Wang, Y., Papadakos, S. P., & Yu, H. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210820114025 · Cited by 47 · see citing works

A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: Effects on proteolytic cleavage and ACE2 binding

Spelios, M. G., Capanelli, J. M., & Li, A. W. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.01.002 · Cited by 9 · see citing works

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity

Essalmani, R., Jain, J., Susan‐Resiga, D., Andréo, U., Evagelidis, A., Derbali, R. M., Huynh, D. N., Dallaire, F., Laporte, M., Delpal, A., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00128-22 · Cited by 183 · see citing works

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)

Xiang, Y., Wang, M., Chen, H., & Chen, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114724 · Cited by 22 · see citing works

Structure–Activity‐Related Analysis of ACE Inhibitory Peptides Against Furin: A Dual‐Action Therapeutic Approach Against SARS‐CoV‐2

Rodhi, A. M., Yap, P., & Gan, C. (2025) · Peptide Science · doi:10.1002/pep2.70013

Why All the Fury over Furin?

Osman, E. E. A., Rehemtulla, A., & Neamati, N. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00518 · Cited by 51 · see citing works